Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder

Depression and Anxiety

Volumn 26, Issue 3, 2009, Pages 212-221

  Adler, Lenard A ^a   Liebowitz, Michael ^b   Kronenberger, William ^c   Qiao, Meihua ^d   Rubin, Richard ^e   Hollandbeck, Millie ^d   Deldar, Ahmed ^d   Schuh, Kory ^d   Durell, Todd ^d,f  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c INDIANA UNIVERSITY   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e Vermont Clinical Study Center   (United States)

^f Lilly USA   (United States)

Author keywords

ADHD; Adults; Atomoxetine; Social anxiety disorder

Indexed keywords

ATOMOXETINE; PLACEBO;

ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PHOBIA; STATE TRAIT ANXIETY INVENTORY; TREATMENT DURATION; XEROSTOMIA;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOBIC DISORDERS; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 63849113971     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20549     Document Type: Article

References (28)

1. Kessler RC, Adler L, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723.
2. Biederman J, Faraone SV, Spencer TJ et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1,001 adults in the community. J Clin Psychiatry 2006;67:524-540.
3. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995;7:373-378.
4. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996;98:1089-1095.
5. Mannuzza S, Klein RG. Long-term prognosis in attention- dencit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9:711-726.
6. Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 2005;23:93-102.
7. Wolraich ML, Lindgren S, Stromquist A et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 1990;86:95-101.
8. DuPaul GJ, Barkley RA, McMurray MB. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 1994;33:894-903.
9. Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 1989;28:882-887.
10. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1088-1096.
11. Abikoff H, McGough J, Vitiello B et al. Sequential pharma- cotherapy for children with comorbid attention-deficit/hyper- activity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 2005;44:418-427.
12. Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003;53:112-120.
13. Adler L, Dietrich A, Reimherr FWet al. Safetyand tolerabilityof once versus twice daily atomoxetine in adults with ADHD. Ann Clin Psychiatry 2006;18:107-113.
14. Wilens TE, Adler LA, Weiss MD et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008;96:145-154.
15. Geller D, Donnelly C, Lopez F et al. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 2007;46:1119-1127.
16. Conners C, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales Technical Manual. North Tonawanda, NY: Multi- Health Systems Inc.; 1999.
17. Adler LA, Goodman DW, Kollins SH et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdex- amfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2008;69:1364-1373.
18. Adler L, Spencer T, Brown TE et al. Once-daily atomoxetine for adult ADHD: a six-month double-blind trial. J Clin Psychopharmacol 2009;29:44-50.
19. Adler LA, Spencer T, Faraone SVet al. Training raters to assess adult ADHD: reliability of ratings. J Atten Disord 2005;8: 121-126.
20. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987;22:141-173.
21. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised 1976. Rockville, MD: National Institute of Mental Health (NIMH), Psychopharmacology Research Branch; 1976.
22. National Institute of Mental Health. Clinical global impressions. Psychopharmacol Bull 1985;21:839-843.
23. Weissman M. MHS Staff. Social Adjustment Scale-Self Report (SAS-SR) User's Manual. North Tonawanda, NY: Multi-Health Systems, Inc.; 1999.
24. Spielberger CD. State-Trait Anxiety Inventory for Adults. Redwood City, CA: Mindgarden Inc.; 1983.
25. Brod M, Perwien AR, Adler L et al. Conceptualization and assessment of quality of life for adults with attention-deficit/ hyperactivity disorder. Prim Psychiatry 2005;12:58-64.
26. Adler LA, Liebowitz M, Qiao M et al. Correlation analyses of the Conners' Adult ADHD Rating Scale and the Liebowitz Social Anxiety Scale administered to adults with attention-deficit/ hyperactivity disorder and comorbid social anxiety disorder following atomoxetine treatment. Presented at the American Academy of Child and Adolescent Psychiatry's 55th Annual Meeting, Chicago, IL; October 29, 2008.
27. Adler LA, Sutton VK, Moore RJ et al. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. J Clin Psychopharmacol 2006;26:648-652.
28. Adler LA, Spencer TJ, Levine LR et al. Functional outcomes in the treatment of adults with ADHD. J Atten Disord 2008; April 30 [Epub ahead of print].